Skip to the page

Data / Form D filings / Affinia Therapeutics Inc.

Affinia Therapeutics Inc.: Form D filings

Affinia Therapeutics Inc., a company in Waltham, MA, filed 4 Form D notices with the SEC between 2019 and 2025. The latest, on October 14, 2025, reports $13.3 million sold of a $45 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
43 FOUNDRY AVE, SUITE 120, Waltham, MA, 02453
Phone
(617) 430-7817
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1792694

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 14, 2025New notice$45,000,000$13,268,335$31,731,66520Sep 16, 2025sec.gov
May 6, 2021New notice$109,999,955$109,999,95522Apr 20, 2021sec.gov
Mar 27, 2020New notice$68,522,920$38,522,942$29,999,97816Mar 12, 2020sec.gov
Nov 5, 2019New notice$8,350,000$8,350,00014Oct 22, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Carole FaigDirector
Rami DaoudExecutive Officer
Robert WeisskoffDirector
Diana BrainardDirector
Rick ModiExecutive Officer, Director
David GrayzelDirector
Luc VandenbergheDirector
Elliott SigalDirector
Edward MathersDirector
Sean NolanDirector

Other companies in Massachusetts that filed recently

Every Form D from the week of Oct 13, 2025 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what Affinia Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.